Amwell boosted its 2026 guidance after a strong third quarter and said it is positioning its unified virtual care platform as infrastructure for AI-enabled care as health plans and employers adopt more tools.
Waystar again topped analyst estimates in the third quarter, citing bigger health system wins and a growing AI pipeline as it sells more of its platform to new and existing clients.
A podcast episode explores whether the growing data from wearables, combined with AI, can improve care for women's heart health, and what it takes to turn information into better outcomes.
Why it matters: Extends hospital operations AI from capacity planning to real-time room monitoring via acquisition.
LeanTaaS is expanding iQueue beyond hospital capacity management by acquiring LookDeep Health, adding computer vision that monitors patient rooms and turns real-time signals into prioritized actions for care teams.
Zocdoc opened its infrastructure to AI agents and announced a partnership with AI personal assistant Instinct, letting agents interact with its scheduling platform.
Why it matters: Lets patients query their own health records through a mainstream AI assistant.
Athenahealth is opening patient health records to outside AI assistants, starting with Anthropic's Claude, via a new MCP connection intended to give patients personalized answers based on their clinical data.
Midstream Health raised a $20 million series A for its AI financial platform, which it says helps hospitals recover lost margin by finding money embedded in contracts and transactions.
A Chinese medical team in Tanzania's Zanzibar is exploring AI tools for radiology, according to a Xinhua feature on the collaboration.
A Distilled Post piece examines the fallout for British doctors whose AI documentation scribe lost its founders, raising questions about reliability and support.
A Bangkok Post piece covers perspectives from the Siriraj x MIT Hacking Medicine 2026 event on where medical AI is heading.
Tech.eu reports SFC Capital is backing Nayara's AI platform for patient care, following the UK healthtech's pre-seed round.
The midterms showed negative sentiment around AI across the U.S.; the piece examines how those attitudes could shape legislation on AI use in health care.
Why it matters: Shows hospitals moving to govern clinicians' fast-spreading chatbot use and its privacy risks.
As hundreds of thousands of doctors consult AI chatbots to make care decisions, health systems are weighing new risks to patient health data and deciding whether to block the tools or buy in.
Medical AI company Lunit plans to issue USD 36 million in convertible bonds to refinance higher-rate debt, Wowtale reports.
An Applied Radiology piece discusses advancing radiology with continuous, ambient, low-friction AI technology that works in the background of imaging workflows.
Why it matters: A major health system platform rolling out a clinician-facing AI tool signals adoption beyond pilots.
Mayo Clinic Platform is rolling out an AI tool for clinicians, according to Modern Healthcare's AI tracker.
NSW Health is seeking legal advice after an AI cancer detection device was scrapped, Health Services Daily reports.
The piece examines the prospect of a 'super AI partner' for patients, weighing what such an assistant could do for consumers navigating their care.
MindWalk (NASDAQ:HYFT) signed a multi-year agreement with Teva Australia covering its AI drug discovery platform, Kalkine reports.
Why it matters: Clinical data from an AI-driven drug pipeline is a key test of the discovery model.
Recursion Pharmaceuticals released Phase 2 REC-4881 trial data and appointed a new board chair alongside Q3 earnings and clinical updates, prompting investor analysis.
A Trend Hunter roundup highlights AI telehealth documentation tools aimed at reducing clinicians' administrative documentation burden during virtual visits.
A Sage Journals article, The Trust Inversion, argues patients are embracing AI alongside their doctors, examining shifting trust dynamics in care.
An npj Digital Medicine paper describes a collaborative generalist-specialist AI approach for safely deprioritizing non-contrast brain CT exams on radiology worklists.
Algorae expanded its pharmaceutical portfolio and validated its AI drug discovery platform, according to TipRanks.
Why it matters: A $50B valuation would make it one of the most valuable AI drug discovery companies.
Alphabet's Isomorphic Labs is reportedly in talks to raise about $5B at a roughly $50B valuation, per Bloomberg, as the AI drug discovery lab scales up.
Portneuf Medical Center in Pocatello, Idaho, added AI and robotic tools to detect lung cancer earlier, according to Idaho Business Review.
A Taipei hospital has built AI to predict acute kidney injury risk, while researchers received a $4M NIH grant to develop an AI model aimed at preventing kidney injury.
Why it matters: State-level rules for ambient AI in exams could shape clinician adoption nationwide.
PYMNTS reports that as AI tools listen in on doctor visits, state legislators are writing rules governing the practice.
Techli reports that one of healthcare AI's hardest tests may be getting a surgical kit to the right room in time, highlighting hospital operations challenges.
Why it matters: A claimed large accuracy gap over physicians would be significant if confirmed.
SingularityHub reports Microsoft's medical AI is over twice as good at diagnosing diseases as doctors, according to the outlet's account.
The Cool Down reports a patient saying a hospital provided her ChatGPT-generated content as her treatment plan.
Stocks Down Under examines why Nvidia invested in Recursion Pharmaceuticals and whether its AI platform could change drug discovery.
University of Central Florida researchers are developing an AI model intended to help physicians improve kidney care, the university announced.
Tsinghua-backed Tairex raised roughly $15M in an angel round to build an AI hospital system, according to Dealroom.
Diagnostic Imaging examines whether radiologists shifting from passive AI users to active AI creators could help address radiology's workforce crisis.
Why it matters: Gives clinicians a free AI tool for personalized medical education alongside OpenEvidence's evidence tool.
OpenEvidence launched Learn, a free AI-powered personalized medical education platform, announced across Morningstar and The Joplin Globe.
Neurotronics received FDA clearance for its AI sleep analysis software, which automates interpretation of sleep studies.
Why it matters: Brings AI assistance to handheld point-of-care ultrasound used outside radiology suites.
GE HealthCare added two AI tools to its Vscan Air handheld ultrasound, according to Medical Product Outsourcing.
Why it matters: Consolidates AI digital pathology under a major lab instruments buyer.
Agilent completed its acquisition of Proscia for up to $270M, expanding AI-powered digital pathology capabilities, citybiz reports.
A new survey found patients are open to doctors using AI for administrative tasks but less enthusiastic about AI for diagnosing conditions or adjudicating claims, preferring human oversight.